October 2009 Volume 5, Issue 10
Volume 5, Issue 10 | October 2009
October 2009
In this Issue
Global News
Dainippon offers $2.6B for Sepracor
Investors object, lawsuits allege Dainippon’s offer is inadequateSingapore sling
Roche adds Lonza facility in Singapore to its growing collection of Asian locationsEvotec AG and Biogen Idec strike screening pact
Evotec will use its technologies to identify hit molecules for BiogenOld pharma friendship bears fruit
Debiopharm to co-develop Ipsen’s Debio 0931 for treatment of cancerMDS sells mass spec business to Danaher for $650 million
Company also seeks buyer for pharma services business as it shifts focus to medical isotopesInformatics
Opening the door to data flow
Collaborative Drug Discovery adds ChemBridge’s screening libraries to growing compound databaseTop-down approach to next-gen
GenomeQuests and Biomatters team up to offer integrated product for next-generation sequencing projectsGlad to know you
The Gladstone Institutes link with Alitora Systems to develop advance knowledge systemsLicense to mine
GeneGo licenses MetaCore to Proteostasis TherapeuticsAutomation & Instrumentation
Taking the next step
Hamilton Robotics and Promega expand their collaborative relationship to co-develop an entire automated systemRight on target for genomics
Affymetrix and Beckman Coulter join forces to provide robust, automated target preparation solutionsCell Biosciences to acquire Alpha Innotech
In a move aimed at creating a global presence in the protein analysis market—with solutions that will range in cost from $5,000 to $200,000—Cell Biosciences Inc. announced in September its acquisition of Alpha Innotech Corp.Mad about rads
PerkinElmer boosts reagents assets with purchase of GE Healthcare's Catalog Radiochemical productsDionex detects growth opportunities with ESA Life Sciences acquisition
Company acquires assets of ESA Life Sciences' tools business to expand HPLC product portfolioGenomics & Proteomics
Music to their ears
Thermo Fisher Scientific to acquire B.R.A.H.M.S., a European provider of specialty diagnostic tests, for $470 millionCompanions in diagnostics
Abbott to develop companion diagnostic for a Pfizer investigational lung cancer therapyRoche gets value with GEMS
Collaboration based on PTC’s novel drug discovery platform to focus on four CNS disease targetsNuevolution connects with Novartis
Partnership will use Nuevolution’s Chemetics technology for lead discoverySilence is golden
UK’s Silence Therapeutics signs siRNA delivery agreement with Japan-based DainipponResearch & Development
Biz booming in biotech hub
North Carolina Biotechnology Center expands headquarters in response to state's continued biotech industry growthWellcome Trust and Merck launch joint venture
Aim is to develop affordable vaccines for low-income countriesGolden opportunity for PsychoGenics and AstraZeneca
Companies to collaborate on finding new treatments for neuropsychiatric disordersTwo peptides are better than one
Amylin and Biocon strike global development and commercialization deal for novel peptide hybrid aimed at treating diabetesNew Products
Next-generation microplate labeler
Agilent Automation Solutions has introduced a new microplate labeling system for automated on-demand, barcode print-and-apply applications in life science laboratories.Core-shell column technology delivers ultra-high performance
Phenomenex Inc. has introduced Kinetex, ultra-high performance LC columns based on the company’s new core-shell silica technology. Kinetex meets researchers’ need to improve results and increase productivity without large capital expenditures.Commentary
Next-gen antibody approaches to cancer treatment offer improved product profiles, greater commercial success
Therapeutic antibodies have changed the cancer treatment landscape over the past decade. Both in liquid and solid tumors, antibodies have become an integral component of treatment regimens that have improved and extended the lives of cancer patients.Patent News
U.S. DOJ hits Pfizer with $2.3 billion fine
How do you know the government is upset about spending all its money on healthcare? When you’re required to pay a record $2.3 billion civil and criminal penalty over unlawful prescription drug promotions.Editor's Focus
Research Triangle Park or bust
I can’t help but wonder what sort of opportunities could be created if the citizens, industry and lawmakers in struggling states such as my own worked together to replicate North Carolina’s success story.News Briefs
Hydra Biosciences, Cubist form collaboration
Hydra Biosciences has announced an agreement with Cubist Pharmaceuticals Inc. for a joint collaboration to develop novel ion channel drugs.Bench Press
OriGene Technologies acquires Marligen Biosciences
OriGene Technologies Inc. announced the acquisition of Marligen Biosciences Inc., a provider of cutting-edge multiplex assays for the Luminex xMAP platform for protein and gene expression profiling assays and testing services, and DNA and RNA purification kits.
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
SubscribeSponsored
Thermo Scientific™ Centrifuges with GreenCool Technology
Next-generation natural refrigerant cooling system for centrifuges, offering a lower Global Warming Potential and reduced energy consumption.
The crucial role of sample preparation in biotherapy manufacturing
Discover how better sample preparation can unlock improved assay accuracy and analytical results.
Discovering deeper insights into malaria research
Malaria continues to drive urgent research worldwide, with new therapies and tools emerging to combat the parasite’s complex lifecycle and global burden.
